Expression and localization of serine protease Htra1 in neuroblastoma: Correlation with cellular differentiation grade

Journal of Neuro-Oncology

Volumn 117, Issue 2, 2014, Pages 287-294

  D'Angelo, Velia ^a   Pecoraro, Giulia ^a   Indolfi, Paolo ^a   Iannotta, Adriana ^a   Donofrio, Vittoria ^b   Errico, Maria Elena ^b   Indolfi, Cristiana ^a   Ramaglia, Maria ^a   Lombardi, Angela ^a   Di Martino, Martina ^a   Gigantino, Vincenzo ^c   Baldi, Alfonso ^a   Caraglia, Michele ^a   De Luca, Antonio ^a   Casale, Fiorina ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b Ospedale Pausilipon   (Italy)

^c NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Ganglioneuroblastoma; HtrA1; Neuroblastoma; Serine protease; Tumour grading

Indexed keywords

HIGH TEMPERATURE REQUIREMENT A1 PROTEIN; SERINE PROTEINASE; UNCLASSIFIED DRUG; HTRA1 PROTEIN, HUMAN; TUMOR MARKER;

ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER REGRESSION; CANCER STAGING; CANCER TISSUE; CHILD; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LOCALIZATION; FEMALE; GENE AMPLIFICATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; MAJOR CLINICAL STUDY; MALE; NEUROBLASTOMA; PRESCHOOL CHILD; PROTEIN EXPRESSION; RECURRENT DISEASE; TUMOR DIFFERENTIATION; WESTERN BLOTTING; CELL DIFFERENTIATION; ENZYMOLOGY; METABOLISM; NEWBORN; PATHOLOGY;

BLOTTING, WESTERN; CELL DIFFERENTIATION; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; INFANT, NEWBORN; MALE; NEOPLASM GRADING; NEOPLASM STAGING; NEUROBLASTOMA; SERINE ENDOPEPTIDASES; TUMOR MARKERS, BIOLOGICAL;

EID: 84901640699     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-014-1387-4     Document Type: Article

References (30)

1. Heck JE, Ritz B, Hung RJ, Hashibe M, Boffetta P (2009) The epidemiology of neuroblastoma: a review paediatric. Perinat Epidemiol 23:125-143
2. Ries L, Eisner M, Kosary C, Hankey B, Miller B, Clegg L (2005) SEER cancer statistics review, 1975-2002. National Cancer Institute, Bethesda
3. Spix C, Pastore G, Sankila R, Stiller CA, Steliarova-Foucher E (2006) Neuroblastoma incidence and survival in European children (1978-1997): report from the Automated Childhood Cancer Information System project. Eur J Cancer 42:2081-2091
4. Gurney JG, Ross JA, Wall DA, Bleyer WA, Severson RK, Robison LL (1997) Infant cancer in the U.S.: histology-specific incidence and trends, 1973 to 1992. J Pediatr Hematol Oncol 19:428-432
5. Gray H, Standring S, Ellis H, Berkovitz BKB (2005) Gray's anatomy: the anatomical basis of clinical practice, 39th edn. Elsevier Churchill Livingstone, Edinburgh
6. Shimada H, Ambros IM, Dehner LP, Hata J, Joshi VV, Roald B, Stram DO, Gerbing RB, Lukens JN, Matthay KK, Castleberry RP (1999) The international neuroblastoma pathology classification (the Shimada system). Cancer 86:364-372
7. Clausen T, Southan C, Ehrmann M (2002) The HtrA family of proteases: implications for protein composition and cell fate. Mol Cell 10:443-445
8. Zumbrunn J, Trueb B (1997) Localization of the gene for a serine protease with IGF binding domain (PRSS11) to human chromosome10q25.3-q26.2. Genomics 45:461-462
9. Hu SI, Carozza M, Klein M, Nantermet P, Luk D, Crowl RM (1998) Human HtrA, an evolutionarily conserved serine protease identified as a differentially expressed gene product in osteoarthritic cartilage. J Biol Chem 273:34406-34412
10. Gray CW, Ward RV, Karran E, Turconi S, Rowles A, Viglienghi D, Southan C, Barton A, Fantom KG, West A, Savopoulos J, Hassan NJ, Clinkenbeard H, Hanning C, Amegadzie B, Davis JB, Dingwall C, Livi GP, Creasy CL (2000) Characterization of human HtrA2, a novel serine protease involved in the mammalian cellular stress response. Eur J Biochem 267:5699-5710
11. Nie GY, Hampton A, Li Y, Findlay JK, Salamonsen LA (2003) Identification and cloning of two isoforms of human high-temperature requirement factor A3 (HtrA3), characterisation of its genomic structure and comparison of its tissue distribution with HtrA1 and HtrA2. Biochem J 37:39-48
12. Oka C, Tsujimoto R, Kajikawa M, Koshiba-Takeuchi K, Ina J, Yano M, Tsuchiya A, Ueta Y, Soma A, Kanda H, Matsumoto M, Kawaichi M (2004) HtrA1 serine protease inhibits signaling mediated by Tgf-β family proteins. Development 131:1041-1053
13. Shridhar V, Sen A, Chien J, Staub J, Avula R, Kovats S, Lee J, Lillie J, Smith DI (2002) Identification of underexpressed genes in early- and late-stage primary ovarian tumors by suppression subtraction hybridization. Cancer Res 62:262-270
14. Baldi A, De Luca A, Morini M, Battista T, Felsani A, Baldi F, Catricala C, Amantea A, Noonan DM, Albini A, Natali PG, Lombardi D, Paggi MG (2002) The HtrAl serine protease is down-regulated during human melanoma progression and repress growth of metastatic melanoma cells. Oncogene 21:6684-6688
15. Chien J, Staub J, Hu SI, Erickson-Johnson MR, Couch FJ, Smith DI, Crowl RM, Kaufmann SH, Shridhar V (2004) A candidate tumor suppressor HtrA1 is down-regulated in ovarian cancer. Oncogene 23:1636-1644
16. De Luca A, De Falco M, Severino A, Campioni M, Santini D, Baldi F, Paggi MG, Baldi A (2003) Distribution of the serine protease HtrA1 in normal human tissues. J Histochem Cytochem 51:1279-1284
17. Zumbrunn J, Trueb B (1996) Primary structure of a putative serine protease specific for IGF-binding proteins. FEBS Lett 398:187-192
18. De Luca A, De Falco M, Fedele V, Cobellis L, Mastrogiacomo A, Laforgia V, Tuduce IL, Campioni M, Giraldi D, Paggi MG, Baldi A (2004) The serine protease HtrA1 is upregulated in the human placenta during pregnancy. J Histochem Cytochem 52:885-892
19. Campioni M, Severino A, Manente L, Tuduce IL, Toldo S, Caraglia M, Crispi S, Ehrmann M, He X, Maguire J, De Falco M, De Luca A, Shridhar V, Baldi A (2010) The serine protease HtrA1 specifically interacts and degrades the tuberous sclerosis complex 2 protein. Mol Cancer Res 8:1248-1260
20. De Luca A, De Falco M, De Luca L, Penta R, Shridhar V, Baldi F, Campioni M, Paggi MG, Baldi A (2004) Pattern of expression of HtrA1during mouse development. J Histochem Cytochem 52:1609-1617
21. Pizzo PA, Poplack DG (eds) (2006) Principles and pratice of pediatric oncology, 5th edn. Lippincott Williams & Wilkins, Philadelphia
22. Seelam B, Kayisli UA, Mulayim N, Arici A (2001) Regulation of Fas ligand expression by estradiol and progesterone in human endometrium. Biol Reprod 65:979-985
23. Bowden MA, Di Nezza-Cossens LA, Jobling T, Salamonsen LA, Nie G (2006) Serine proteases HtrA1 and HtrA3 are down-regulated with increasing grades of human endometrial cancer. Gynecol Oncol 103:253-260
24. Suzuki Y, Takahashi-Niki K, Akagi T, Hashikawa T, Takahashi R (2004) Mitochondrial protease Omi/HtrA2 enhances caspase activation through multiple pathways. Cell Death Differ 11:208-216
25. Spugnini EP, Cardillo I, Verdina A, Crispi S, Saviozzi S, Calogero R, Nebbioso A, Altucci L, Cortese G, Galati R, Chien J, Shridhar V, Vincenzi B, Citro G, Cognetti F, Sacchi A, Baldi A (2006) Piroxicam and cisplatin in a mouse model of peritoneal mesothelioma. Clin Cancer Res 12(20):6133-6143
26. Esposito V, Campioni M, De Luca A, Spugnini EP, Baldi F, Cassandro R, Mancini A, Vincenzi B, Groeger A, Caputi M, Baldi A (2006) Analysis of HtrA1 serine protease expression in human lung cancer. Anticancer Res 26:3455-3460
27. Narkiewicz J, Klasa-Mazurkiewicz D, Zurawa-Janicka D, Skorko-Glonek J, Emerich J, Lipinska B (2008) Changes in mRNA and protein levels of human HtrA1, HtrA2 and HtrA3 in ovarian cancer. Clin Biochem 41:561-569
28. Drubin DA, Clawson GA (2004) Spontaneous transformation of an immortalized hepatocyte cell line: potential role of a nuclear protease. Cancer Lett 15:39-48
29. Lázcoz P, Muñoz J, Nistal M, Pestaña A, Encío IJ, Castresana JS (2007) Loss of heterozygosity and microsatellite instability on chromosome arm 10q in neuroblastoma. Cancer Genet Cytogenet 1:1-8
30. Chien J, Aletti G, Baldi A, Catalano V, Muretto P, Keeney GL, Kalli KR, Staub J, Ehrmann M, Cliby WA, Lee YK, Bible KC, Hartmann LC, Kaufmann SH, Shridhar V (2006) Serine protease HtrA1modulates chemotherapy-induced cytotoxicity. J Clin Invest 116:1994-2004